Jenkins Annalisa has filed 21 insider transactions across 4 companies since May 2023.
Most recent transaction: a grant/award of 75000 shares of Skye Bioscience, Inc. ($SKYE) on March 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | Jenkins Annalisa | Director | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 39,665,927 | 9999.99% | 0.19% |
| Feb. 26, 2026 | Mereo BioPharma Group plc | $MREO | Jenkins Annalisa | Not found | A | Deferred Restricted Stock Units | 106848 | $0.00 | 106,848.0000 | 799,947,013 | 9999.99% | 0.01% |
| Feb. 26, 2026 | Mereo BioPharma Group plc | $MREO | Jenkins Annalisa | Not found | A | Share Options (Right to buy) | 66000 | $0.00 | 66,000.0000 | 799,947,013 | 9999.99% | 0.01% |
| Feb. 6, 2026 | Skye Bioscience, Inc. | $SKYE | Jenkins Annalisa | Director | A | Stock Option (Right to Buy) | 35000 | $0.00 | 35,000.0000 | 39,665,927 | 9999.99% | 0.09% |
| June 12, 2025 | COMPASS Pathways plc | $CMPS | Jenkins Annalisa | Director | A | Share Option (Right to Buy) | 26000 | $0.00 | 26,000.0000 | 92,673,132 | 9999.99% | 0.03% |
| Feb. 24, 2025 | Skye Bioscience, Inc. | $SKYE | Jenkins Annalisa | Director | A | Stock Option (Right to Buy) | 35000 | $0.00 | 35,000.0000 | 36,486,519 | 9999.99% | 0.10% |
| Feb. 5, 2025 | Mereo BioPharma Group plc | $MREO | Jenkins Annalisa | Not found | A | Share Options (Right to buy) | 55000 | $0.00 | 55,000.0000 | 739,624,264 | 9999.99% | 0.01% |
| Feb. 5, 2025 | Mereo BioPharma Group plc | $MREO | Jenkins Annalisa | Not found | A | Deferred Restricted Stock Units | 15243 | $0.00 | 15,243.0000 | 739,624,264 | 9999.99% | 0.00% |
| Oct. 28, 2024 | Skye Bioscience, Inc. | $SKYE | Jenkins Annalisa | Director | A | Stock Option (Right to Buy) | 70000 | $0.00 | 70,000.0000 | 38,819,387 | 9999.99% | 0.18% |
| Aug. 1, 2024 | COMPASS Pathways plc | $CMPS | Jenkins Annalisa | Director | F | Ordinary Shares | 161 | $6.88 | 19,480.0000 | 0 | 0.82% | 0.00% |
| May 9, 2024 | COMPASS Pathways plc | $CMPS | Jenkins Annalisa | Director | A | Share Option (Right to Buy) | 26000 | $0.00 | 26,000.0000 | 0 | 9999.99% | 0.00% |
| May 1, 2024 | COMPASS Pathways plc | $CMPS | Jenkins Annalisa | Director | F | Ordinary Shares | 211 | $8.48 | 19,641.0000 | 0 | 1.06% | 0.00% |
| Feb. 29, 2024 | Skye Bioscience, Inc. | $SKYE | Jenkins Annalisa | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 7,006,038 | 9999.99% | 0.57% |
| Feb. 8, 2024 | Mereo BioPharma Group plc | $MREO | Jenkins Annalisa | Not found | A | Share Options (Right to buy) | 45000 | $0.00 | 45,000.0000 | 659,453,921 | 9999.99% | 0.01% |
| Feb. 8, 2024 | Mereo BioPharma Group plc | $MREO | Jenkins Annalisa | Not found | A | Deferred Restricted Stock Units | 14947 | $0.00 | 14,947.0000 | 659,453,921 | 9999.99% | 0.00% |
| Feb. 1, 2024 | COMPASS Pathways plc | $CMPS | Jenkins Annalisa | Director | F | Ordinary Shares | 175 | $11.34 | 19,852.0000 | 0 | 0.87% | 0.00% |
| Nov. 1, 2023 | COMPASS Pathways plc | $CMPS | Jenkins Annalisa | Director | F | Ordinary Shares | 143 | $5.78 | 20,027.0000 | 0 | 0.71% | 0.00% |
| Aug. 1, 2023 | COMPASS Pathways plc | $CMPS | Jenkins Annalisa | Director | F | Ordinary Shares | 161 | $8.95 | 20,170.0000 | 0 | 0.79% | 0.00% |
| June 6, 2023 | Tectonic Therapeutic, Inc. | $TECX | Jenkins Annalisa | Director | A | Stock Option (Right to Buy) | 17643 | $0.00 | 17,643.0000 | 0 | 9999.99% | 0.00% |
| June 2, 2023 | COMPASS Pathways plc | $CMPS | Jenkins Annalisa | Director | A | Share Option (Right to Buy) | 26000 | $0.00 | 26,000.0000 | 0 | 9999.99% | 0.00% |
| May 2, 2023 | COMPASS Pathways plc | $CMPS | Jenkins Annalisa | Director | F | Ordinary Shares | 25 | $7.97 | 20,331.0000 | 0 | 0.12% | 0.00% |